Effects of dextromethorphan on the seizures induced by kainate and the calcium channel agonist BAY k-8644: comparison with the effects of dextrorphan.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Behavioural Brain Research

• Publication date

  2001-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0166-4328(00)00372-7PMID 11182165
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dextromethorphan modulates the AP-1 DNA-binding activity induced by kainic acid.

  1999cited by this paper
• L-type voltage-gated calcium channels modulate kainic acid neurotoxicity in cerebellar granule cells.

  1999cited by this paper
• A single dose of kainic acid elevates the levels of enkephalins and activator protein-1 transcription factors in the hippocampus for up to 1 year.

  1997cited by this paper
• Dextromethorphan blocks opioid peptide gene expression in the rat hippocampus induced by kainic acid.

  1997cited by this paper
• l-2-Chloropropionic acid-induced cerebellar granule cell necrosis is potentiated by L-type calcium channel antagonists

  1997cited by this paper
• Role of voltage dependent calcium channels and cholinergic receptors in the convulsant action of BAY k-8644.

  1997cited by this paper
• Long-term expression of the 35,000 mol. wt fos-related antigen in rat brain after kainic acid treatment.

  1996cited by this paper
• The effects of dextromethorphan on kainic acid-induced seizures in the rat.

  1996cited by this paper
• Anti- and proconvulsive actions of levcromakalim, an opener of ATP-sensitive K+ channel, in the model of hippocampus-generating partial seizures in rats.

  1996cited by this paper
• Role of L‐Type Calcium Channel Modulation in Nonconvulsive Epilepsy in Rats

  1995cited by this paper
• Effects of route of administration on dextromethorphan pharmacokinetics and behavioral response in the rat.

  1995cited by this paper
• Implications of prolonged expression of Fos-related antigens.

  1995cited by this paper
• Discriminative stimulus effects of dextromethorphan in the rat

  1994cited by this paper
• Novel anticonvulsant analogs of dextromethorphan: improved efficacy, potency, duration and side-effect profile.

  1994cited by this paper
• Antagonism of various tonic convulsions in mice by dextrorphan and dizocilpine

  1993cited by this paper
• Effect of Bay K 8644 on the synthesis and metabolism of dopamine and 5‐hydroxytryptamine in various brain areas of the rat

  1993cited by this paper
• Differences in anticonvulsant potency and adverse effects between dextromethorphan and dextrorphan in amygdala-kindled and non-kindled rats.

  1993cited by this paper
• Dextromethorphan blocks N-methyl-D-aspartate-induced currents and voltage-operated inward currents in cultured cortical neurons.

  1993cited by this paper
• Effects of antiepileptic drugs, calcium channel blockers and other compounds on seizures induced by activation of voltage-dependent L calcium channel in DBA/2 mice.

  1992cited by this paper
• Effect of different convulsants on calmodulin levels and proto-oncogene c-fos expression in the central nervous system.

  1992cited by this paper
• Induction of phencyclidine-like behavior in rats by dextrorphan but not dextromethorphan.

  1991cited by this paper
• L-type voltage-sensitive calcium channels mediate synaptic activation of immediate early genes.

  1991cited by this paper
• Proto-oncogene transcription factors and epilepsy.

  1991cited by this paper
• The effect of nimodipine on picrotoxin-induced seizures.

  1990cited by this paper
• The effects of dihydropyridine calcium channel modulators on pentylenetetrazole convulsions.

  1990cited by this paper
• Dextromethorphan and sigma ligands: common sites but diverse effects.

  1989cited by this paper
• Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes after seizure.

  1989cited by this paper
• Calcium, neuronal hyperexcitability and ischemic injury.

  1989cited by this paper
• Dextromethorphan and neuromodulation: old drug coughs up new activities.

  1989cited by this paper
• Non-competitive N-methyl-D-aspartate antagonists protect against sound-induced seizures in DBA/2 mice.

  1989cited by this paper
• Modulation of neurotransmitter metabolism by dihydropyridine calcium channel ligands in mouse brain.

  1988cited by this paper
• Anticonvulsant effects of dextrorphan in rats: possible involvement in dextromethorphan-induced seizure protection.

  1988cited by this paper
• Dextromethorphan inhibits NMDA-induced convulsions.

  1988cited by this paper
• The Ca++-antagonist nimodipine decreases and the Ca++-agonist Bay K 8644 increases catecholamine synthesis in mouse brain.

  1987cited by this paper
• Suppression of Pentylenetetrazole Seizures by Oral Administration of a Dihydropyridine Ca2+ Antagonist

  1987cited by this paper
• Induction of seizures in mice by intracerebroventricular administration of the calcium channel agonist BAY k 8644.

  1987cited by this paper
• 4-Aminopyridine-mediated increase in long-term potentiation in CA1 of the rat hippocampus.

  1986cited by this paper
• The behavioral effects of the calcium agonist BAY K 8644 in the mouse: Antagonism by the calcium antagonist nifedipine

  1985cited by this paper
• The agonist effect of dihydropyridines on Ca channels

  1984cited by this paper
• Modification of seizure activity by electrical stimulation. II. Motor seizure.

  1972cited by this paper
• Accurate freehand injection into the lateral brain ventricle of the conscious mouse.

  1968cited by this paper
• Novel Anticonvulsant Analogs of Dextromethorphan : Improved Efficacy , Potency , Duration and Side-Effect Profile 1

  year unknowncited by this paper

• Aging clocks delineate neuron types vulnerable or resilient to neurodegeneration and identify neuroprotective interventions.

  2026cites this paper
• Ginsenoside Re blocks Bay k-8644-induced neurotoxicity via attenuating mitochondrial dysfunction and PKCδ activation in the hippocampus of mice: Involvement of antioxidant potential.

  2023cites this paper
• Anti-epileptic and Neuroprotective Effects of Ultra-low Dose NADPH Oxidase Inhibitor Dextromethorphan on Kainic Acid-induced Chronic Temporal Lobe Epilepsy in Rats

  2023cites this paper
• Sigma-1 receptor and seizures

  2023cites this paper
• The effect of acute administration of quinidine, dextromethorphan and combination of dextromethorphan/quinidine on pentylenetetrazole-induced clonic and tonic seizure thresholds in mice

  2019cites this paper
• Optoelectronic method for increasing the sensibility of mass spectrometer in the case of the determination of papaverine

  2018cites this paper
• MK‐801, but not naloxone, attenuates high‐dose dextromethorphan‐induced convulsive behavior: Possible involvement of the GluN2B receptor

  2017cites this paper
• Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders.

  2016influential citation
• Dextromethorphan-induced psychotoxic behaviors cause sexual dysfunction in male mice via stimulation of σ-1 receptors.

  2012cites this paper
• Dextromethorphan abuse masquerading as a recurrent seizure disorder.

  2011cites this paper
• Neuropsychotoxic and neuroprotective potentials of dextromethorphan and its analogs.

  2011cites this paper
• The NMDA receptor complex as a therapeutic target in epilepsy: a review.

  2011cites this paper
• Neuropsychopharmacological understanding for therapeutic application of morphinans

  2010cites this paper
• Effects of dextromethorphan on electroconvulsive therapy

  2009cites this paper
• BAY-K 8644

  2008cites this paper
• Neuropsychotoxicity of abused drugs: potential of dextromethorphan and novel neuroprotective analogs of dextromethorphan with improved safety profiles in terms of abuse and neuroprotective effects.

  2008cites this paper
• Concise synthesis of dimemorfan (DF) starting from 3-hydroxymorphinan (3-HM).

  2008cites this paper
• Effects of dextrorotatory morphinans on brain Na+ channels expressed in Xenopus oocytes.

  2007cites this paper
• Dextromethorphan attenuates trimethyltin-induced neurotoxicity via σ1 receptor activation in rats

  2007cites this paper
• Dextromethorphan attenuates trimethyltin-induced neurotoxicity via sigma1 receptor activation in rats.

  2007cites this paper
• Effects of dextrorotatory morphinans on alpha3beta4 nicotinic acetylcholine receptors expressed in Xenopus oocytes.

  2006cites this paper
• Effects of dextrorotatory morphinans on α3β4 nicotinic acetylcholine receptors expressed in Xenopus oocytes

  2006cites this paper
• The dextromethorphan analog dimemorfan attenuates kainate‐induced seizures via σ1 receptor activation: comparison with the effects of dextromethorphan

  2005cites this paper
• Simultaneous determination of phenytoin and dextromethorphan in urine by solid-phase extraction and HPLC-DAD.

  2005cites this paper
• Dimemorfan prevents seizures induced by the L-type calcium channel activator BAY k-8644 in mice.

  2004cites this paper
• A review of neuroprotective agents.

  2004cites this paper
• Morphinan neuroprotection: new insight into the therapy of neurodegeneration.

  2004cites this paper
• New morphinan derivatives with negligible psychotropic effects attenuate convulsions induced by maximal electroshock in mice.

  2003cites this paper
• Metabolism to dextrorphan is not essential for dextromethorphan's anticonvulsant activity against kainate in mice.

  2003cites this paper
• Excitatory Amino Acid-Elicited Tonic Convulsions in Mice and N-Methyl-D-Aspartate Receptor Activation: Role of Ca2+ Influx and Involvement of Intracellular Ca2+-Dependent Biochemical Processes

  2002cites this paper